INNOGEN-B Maintains Stable Share Capital Structure in July 2026; Confirms Public Float Compliance

Bulletin Express08-05

Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for Equity Issuer for the month ended 31 July 2026, indicating no movements in authorised, issued or treasury shares during the period.

Authorised/Registered Capital • Total authorised share capital stood unchanged at 456.82 million ordinary shares with a par value of RMB 1 each. • This total comprises 420.29 million H shares listed on the Hong Kong Stock Exchange and 36.53 million unlisted domestic shares.

Issued Share Capital and Treasury Shares • Issued share capital mirrored the authorised figures at 456.82 million shares. • No treasury shares were recorded, and there were no repurchases, cancellations or redemptions during the month.

Public Float • The company affirmed compliance with the Main Board’s minimum public float requirement of 25 percent for its H-share class as of 31 July 2026.

Capital-Raising Instruments • The return reported no outstanding share options, warrants, convertible securities, or other agreements that could dilute existing share capital. • There were no Hong Kong Depositary Receipts (HDRs) in issue.

The unchanged capital structure underscores the company’s stable equity position through July 2026, with regulatory float thresholds fully satisfied.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1166745114?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 17:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166745114","market":"hk","top_or_hot":-1,"title":"INNOGEN-B Maintains Stable Share Capital Structure in July 2026; Confirms Public Float Compliance","media":"Bulletin Express","content":"<p>Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for Equity Issuer for the month ended 31 July 2026, indicating no movements in authorised, issued or treasury shares during the period.</p>\n<p>Authorised/Registered Capital  \n• Total authorised share capital stood unchanged at 456.82 million ordinary shares with a par value of RMB 1 each.  \n• This total comprises 420.29 million H shares listed on the Hong Kong Stock Exchange and 36.53 million unlisted domestic shares.</p>\n<p>Issued Share Capital and Treasury Shares  \n• Issued share capital mirrored the authorised figures at 456.82 million shares.  \n• No treasury shares were recorded, and there were no repurchases, cancellations or redemptions during the month.</p>\n<p>Public Float  \n• The company affirmed compliance with the Main Board’s minimum public float requirement of 25 percent for its H-share class as of 31 July 2026.</p>\n<p>Capital-Raising Instruments  \n• The return reported no outstanding share options, warrants, convertible securities, or other agreements that could dilute existing share capital.  \n• There were no Hong Kong Depositary Receipts (HDRs) in issue.</p>\n<p>The unchanged capital structure underscores the company’s stable equity position through July 2026, with regulatory float thresholds fully satisfied.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INNOGEN-B Maintains Stable Share Capital Structure in July 2026; Confirms Public Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINNOGEN-B Maintains Stable Share Capital Structure in July 2026; Confirms Public Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-05 17:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for Equity Issuer for the month ended 31 July 2026, indicating no movements in authorised, issued or treasury shares during the period.</p>\n<p>Authorised/Registered Capital  \n• Total authorised share capital stood unchanged at 456.82 million ordinary shares with a par value of RMB 1 each.  \n• This total comprises 420.29 million H shares listed on the Hong Kong Stock Exchange and 36.53 million unlisted domestic shares.</p>\n<p>Issued Share Capital and Treasury Shares  \n• Issued share capital mirrored the authorised figures at 456.82 million shares.  \n• No treasury shares were recorded, and there were no repurchases, cancellations or redemptions during the month.</p>\n<p>Public Float  \n• The company affirmed compliance with the Main Board’s minimum public float requirement of 25 percent for its H-share class as of 31 July 2026.</p>\n<p>Capital-Raising Instruments  \n• The return reported no outstanding share options, warrants, convertible securities, or other agreements that could dilute existing share capital.  \n• There were no Hong Kong Depositary Receipts (HDRs) in issue.</p>\n<p>The unchanged capital structure underscores the company’s stable equity position through July 2026, with regulatory float thresholds fully satisfied.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02591","symbol_name":"银诺医药-B","start_time":0,"source_url":"","article_id":"1166745114","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166745114","pubTimestamp":1785922074,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for Equity Issuer for the month ended 31 July 2026, indicating no movements in authorised, issued or treasury...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02591":"银诺医药-B"},"translate_title":"INNOGEN-B于2026年7月保持稳定的股本结构；确认公众持股量合规性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02591":1},"content_text":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for Equity Issuer for the month ended 31 July 2026, indicating no movements in authorised, issued or treasury shares during the period.\nAuthorised/Registered Capital  \n• Total authorised share capital stood unchanged at 456.82 million ordinary shares with a par value of RMB 1 each.  \n• This total comprises 420.29 million H shares listed on the Hong Kong Stock Exchange and 36.53 million unlisted domestic shares.\nIssued Share Capital and Treasury Shares  \n• Issued share capital mirrored the authorised figures at 456.82 million shares.  \n• No treasury shares were recorded, and there were no repurchases, cancellations or redemptions during the month.\nPublic Float  \n• The company affirmed compliance with the Main Board’s minimum public float requirement of 25 percent for its H-share class as of 31 July 2026.\nCapital-Raising Instruments  \n• The return reported no outstanding share options, warrants, convertible securities, or other agreements that could dilute existing share capital.  \n• There were no Hong Kong Depositary Receipts (HDRs) in issue.\nThe unchanged capital structure underscores the company’s stable equity position through July 2026, with regulatory float thresholds fully satisfied.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1166745114","isCrawlerRequest":true}